Hsu P, Choi EJ, Patel SA, Wong WH, et al. Responsiveness to Vedolizumab Therapy in Ulcerative Colitis is Associated With Alterations in Immune Cell-Cell Communications. Inflamm Bowel Dis 2023 May 26:izad084. doi: 10.1093.
PMID: 37235748